Novel Monitoring and Dose Adjustment of Argatroban, a Direct Thrombin Inhibitor, to Maintain Therapeutic Anticoagulation in a Patient With Antiphospholipid Antibody Syndrome, Heparin-Induced Thrombocytopenia, and COVID-19 Pneumonia

In patients who require systemic anticoagulation, a reliable monitoring method is required to ensure anticoagulation is maintained within the correct therapeutic window and patients are treated appropriately. When titrating direct thrombin inhibitors (DTIs), dilute thrombin time (dTT) measurements h...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryan, Christine E., Newman, Kelly A., Roberts, Russel J., Frydman, Galit H., Rosovsky, Rachel P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129108/
https://www.ncbi.nlm.nih.gov/pubmed/37114202
http://dx.doi.org/10.1097/CCE.0000000000000903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129108/
https://www.ncbi.nlm.nih.gov/pubmed/37114202
http://dx.doi.org/10.1097/CCE.0000000000000903

Ejemplares similares